MediciNova Receives a Notice of European Patent Allowance for Treating … – NASDAQ

MediciNova Receives a Notice of European Patent Allowance for Treating
NASDAQ
MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis
MediciNova Receives Notice of European Patent Allowance for Treating Benzinga

all 3 news articles »

View full post on asthma – Google News